Annals of oncology : official journal of the European Society for Medical Oncology

The most recent articles from: Ann. Oncol. September 2016

Ann. Oncol. · Sep 2016

Multicenter Study

Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET).

This European phase IIIb, expanded-access multicenter trial evaluated the safety of EVE plus EXE in a patient population similar to BOLERO-2. ⋯ EudraCT Number: 2012-000073-23.

expand abstract… or not…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.